StockData
Skinvisible, Inc. logo

Skinvisible, Inc. (SKVI) stock

SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.16+0.00 (+0.06%)

Close on Oct 19, 2026Market cap $843.54KP/E –Yield –

Skinvisible net income

Net income is the profit left for shareholders after every expense, interest and tax.

Skinvisible's net income for the twelve months ending Jun 30, 2026 was -$1.03M. For fiscal 2025 it was -$1.06M. The highest annual figure on record is $158.34K in fiscal 2018.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.06M–
FY2024Dec 31, 2024-$565.65K–
FY2023Dec 31, 2023-$2.38M–
FY2022Dec 31, 2022-$1.22M–
FY2021Dec 31, 2021-$1.07M–
FY2020Dec 31, 2020-$1.45M–
FY2019Dec 31, 2019-$1.70M-1175.0%
FY2018Dec 31, 2018$158.34K–
FY2017Dec 31, 2017-$1.83M–
FY2016Dec 31, 2016-$2.05M–
FY2015Dec 31, 2015-$1.99M–
FY2014Dec 31, 2014-$1.93M–
FY2013Dec 31, 2013-$1.34M–
FY2012Dec 31, 2012-$1.45M–
FY2011Dec 31, 2011-$1.36M–
FY2010Dec 31, 2010-$1.07M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$255.53K–
Q1 FY2026Mar 31, 2026-$267.18K–
Q4 FY2025Dec 31, 2025-$258.36K-182.1%
Q3 FY2025Sep 30, 2025-$250.25K–
Q2 FY2025Jun 30, 2025-$274.43K–
Q1 FY2025Mar 31, 2025-$281.01K–
Q4 FY2024Dec 31, 2024$314.77K–
Q3 FY2024Sep 30, 2024-$286.60K–
Q2 FY2024Jun 30, 2024-$303.45K–
Q1 FY2024Mar 31, 2024-$290.37K–
Q4 FY2023Dec 31, 2023-$303.79K–
Q3 FY2023Sep 30, 2023-$287.52K–
Q2 FY2023Jun 30, 2023-$276.08K–
Q1 FY2023Mar 31, 2023-$1.52M–
Q4 FY2022Dec 31, 2022-$400.58K–
Q3 FY2022Sep 30, 2022-$418.07K–
Q4 FY2021Dec 31, 2021-$165.38K–
Q3 FY2021Sep 30, 2021-$203.35K–
Q2 FY2021Jun 30, 2021-$268.51K–
Q1 FY2021Mar 31, 2021-$435.51K–
Q4 FY2020Dec 31, 2020-$294.98K–
Q3 FY2020Sep 30, 2020-$409.76K–
Q2 FY2020Jun 30, 2020-$312.79K–
Q1 FY2020Mar 31, 2020-$430.08K–
Q4 FY2019Dec 31, 2019-$427.28K–
Q3 FY2019Sep 30, 2019-$348.74K-154.8%
Q2 FY2019Jun 30, 2019-$583.01K–
Q1 FY2019Mar 31, 2019-$343.10K-455.4%
Q4 FY2018Dec 31, 2018-$177.63K–
Q3 FY2018Sep 30, 2018$636.10K–
Q2 FY2018Jun 30, 2018-$396.66K–
Q1 FY2018Mar 31, 2018$96.53K–
Q4 FY2017Dec 31, 2017-$123.30K–
Q3 FY2017Sep 30, 2017-$552.27K–
Q2 FY2017Jun 30, 2017-$672.26K–
Q1 FY2017Mar 31, 2017-$478.98K–
Q4 FY2016Dec 31, 2016-$473.57K–
Q3 FY2016Sep 30, 2016-$483.99K–
Q2 FY2016Jun 30, 2016-$463.93K–

More Skinvisible figures

See a number that looks wrong?